New Data Can Start A New Conversation (ACR Convergence 2026) - Oct 28, 2026 - Pres time: Nov 8, 2026; 01:30 PM - 02:15 PM; Location: Innovation Theater B; In Person; "Please note: This session is not eligible for CE Credits through the ACR.A Product Theater for Taltz® (ixekizumab) and Zepbound® (tirzepatide) Single-Dose Pen including information about an Affordability Program for Eligible, Commercially Insured Taltz Patients Prescribed Zepbound. Developed and offered by Lilly.Not an official program of the ACR."
|